|
|
||||||||
From the Department of Molecular Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037
Abstract
The reaction of purified C5b-6 with purified C7, C8, and C9 was studied in cellfree solution. C5b-6 binds C7, C8, and C9 in a sequential manner and thereby forms hemolytically inactive complexes. Calculations of molar ratios indicate the binding of multiple C9 molecules per C5b-8 complex, which contains equimolar amounts of C5b, C6, C7, and C8.
The dissociation constants for the terminal components were calculated from Scatchard plots: KD (C7) = 0.2 to 2.9 x 10-12 M, KD (C8) = 0.9 to 8.6 x 10-12 M, and KD (C9) = 0.1 to 0.5 x 10-12 M. The free energy for C5b-9 formation from C5b-6, C7, C8, and C9 is estimated to be -50 kcal/mole.
Inactivation of C5b-6 by C7 is a rapid, time and temperature dependent process following second order kinetics. Complex formation at 37°C is diffusion controlled; at 4°C it is, in addition, controlled by activation energy requirement since the activation energy for complex formation was found to be 33.7 kcal/mole. Association of C5b-6 and C7 results in the formation of a labile membrance binding site, C5b-7*, which decays rapidly to yield C5b-7i. C5b-7 formation from its precursors C5b-6 and C7 is the rate limiting step, decay of C5b-7* to C5b-7i is rapid compared to the association reaction.
The following thermodynamic parameters were obtained at 30°C for the C5b-7i formation from C5b-6 and C7:
G = -17 kcal/mole,
H = +8.6 kcal/mole and
S = 77 e.u. The data are compatible with the interpretation that the protein-protein interactions occurring upon complex formation are accompanied by release of protein bound water or by conformational changes or both. C5b-7 formation results in acquisition of a labile binding site, a markedly anodal electrophoretic mobility, expression of a second neoantigen, and in aggregation in the absence of cells or the S-protein.
Footnotes
1 This work was supported by United States Public Health Service Grants AI 07007 and HL 16411. This is Publication No. 1487 from the Research Institute of Scripps Clinic.
2 Recipient of Investigatorship. PO 167-1 and PO 167-2 from the Deutsche Forschungsgemeinschaft.
3 Supported by United States Public Health Service Training Grant HI 07195.
4 Recipient of Research Career Development Award 5 KO4 CA 70841 from the United States Public Health Service. Present address: Department of Biochemistry, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284.
5 Cecil H. and Ida M. Green Investigator in Medical Research, Research Institute of Scripps Clinic.
This article has been cited by other articles:
![]() |
C.-T. Thai and R. T. Ogata Recombinant C345C and Factor I Modules of Complement Components C5 and C7 Inhibit C7 Incorporation into the Complement Membrane Attack Complex J. Immunol., May 15, 2005; 174(10): 6227 - 6232. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |